Yes, on June 29, 2023, the CDC recommended two new RSV vaccines for adults age 60 and up. There are two available single-dose vaccines—one developed by Pfizer (called Abrysvo) and the other developed by GSK (called Arexvy). Both vaccines were determined to be equally effective by the CDC Advisory Committee on Immunization Practices (ACIP) after reviewing results from clinical trials and are currently available. People age 60 years and up should receive an RSV vaccine after consulting with their healthcare provider.
Added December 14, 2023